Uploaded October 2026 | Updated November 2026, 4 hours ago
Michael Benatar, MD, PhD, Department of Neurology and ALS Center, University of Miami Miller School of Medicine, discusses the use of plasma proteomics in predicting clinical manifestations of amyotrophic lateral sclerosis (ALS).
For the full interview, visit checkrare.com/plasma-proteomics-may-predict-disease-manifestations-in-als
Michael Benatar, MD, PhD, Department of Neurology and ALS Center, University of Miami Miller School of Medicine, discusses the use of plasma proteomics in predicting clinical manifestations of amyotrophic lateral sclerosis (ALS).
For the full interview, visit checkrare.com/plasma-proteomics-may-predict-disease-manifestations-in-als










